HCA Midwest Division - Sarah Cannon Cancer Institute — Kansas City, Missouri

HCA Midwest Division - Sarah Cannon Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

HCA Midwest Division - Sarah Cannon Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Platinum Resistant Ovarian Cancer.

Sponsors: Mateon Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Division - Sarah Cannon Cancer Institute?

HCA Midwest Division - Sarah Cannon Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Division - Sarah Cannon Cancer Institute conducted?

HCA Midwest Division - Sarah Cannon Cancer Institute has 1 clinical trials on record. Their work covers Platinum Resistant Ovarian Cancer.

Is HCA Midwest Division - Sarah Cannon Cancer Institute accredited by Crixeo Health?

HCA Midwest Division - Sarah Cannon Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Division - Sarah Cannon Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.